2013 CPhI Pharma Awards - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

2013 CPhI Pharma Awards

CPhI is now accepting applications for the 2013 CPhI Pharma Awards, open to individuals and companies who have developed innovations in pharma over the past year.

About the Awards
For nine years, the CPhI Pharma Awards have recognized thought leadership on a global scale, unveiling top pharma innovators to global trade press during the leading pharmaceutical event.

Learn more about the Awards
Benefits of Entering

Finalists will be notified in September 2013, and will present their innovations on the CPhI show floor on Oct. 22, 2013. The CPhI Pharma Awards ceremony and party are scheduled for the evening of Oct. 22 in the Messe Frankfurt Europa Room.

Awards are presented in three categories:
Innovation in Formulation
Entries in the Innovation in Formulation category should pertain to the following topics: Drug Delivery, Excipients, Controlled Release, Stability, or Bio Availability.

Innovation in Process Development
Entries in the Innovation in Process Development category should pertain to the following topics: Synthesis, Crystalization, Polymorphism, Catalysts or Green Chemistry.

Innovation in Packaging
Entries in the Innovation in Packaging category should pertain to the following topics: Primary Packaging, Devices & Technology, Patient Compliance, Dispensers, Materials, Counterfeit Technologies.

Learn more about the categories.

Entry Process

The CPhI Pharma Awards are open for pharmaceutical professionals working in roles spanning the entire pharma industry. CPhI Worldwide 2013 exhibitors can enter free of charge. Registered visitors can enter with a €95 application fee. Entrants must submit the appropriate application by Friday, July 26, 2013.

For more information, visit www.cphi.com/awards.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here